2017 - NANETS https://nanets.net/abstracts-archive/2017?format=html Thu, 15 Feb 2018 14:23:32 -0500 en-GB hourly 1 T07 – ElevatION:NET-201 An Open-Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-Differentiated, Non-Functional NET of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-Differen https://nanets.net/abstracts-archive/2017/602-t07-elevation-net-201-an-open-label-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-pdr001-in-patients-with-advanced-or-metastatic-well-differentiated-non-functional-net-of-pancreatic-gastrointestinal-gi-or-thoracic-origin-or-poorly-differentiated?format=html T07 – ElevatION:NET-201 An Open-Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-Differentiated, Non-Functional NET of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-Differen Yao

Abstract ID: 242

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/602-t07-elevation-net-201-an-open-label-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-pdr001-in-patients-with-advanced-or-metastatic-well-differentiated-non-functional-net-of-pancreatic-gastrointestinal-gi-or-thoracic-origin-or-poorly-differentiated?format=html Yao

Abstract ID: 242

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:23:32 -0500 T06 – Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET) https://nanets.net/abstracts-archive/2017/601-t06-randomized-embolization-trial-for-neuroendocrine-tumor-metastases-to-the-liver-retnet?format=html T06 – Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET) Soulen

Abstract ID: 311

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/601-t06-randomized-embolization-trial-for-neuroendocrine-tumor-metastases-to-the-liver-retnet?format=html Soulen

Abstract ID: 311

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:23:31 -0500 T05 – Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of 177Lu-OPS201 as Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors https://nanets.net/abstracts-archive/2017/600-t05-phase-1-2-open-label-trial-to-assess-the-safety-and-preliminary-efficacy-of-177lu-ops201-as-peptide-receptor-radionuclide-therapy-in-patients-with-somatostatin-receptor-positive-progressive-neuroendocrine-tumors?format=html T05 – Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of 177Lu-OPS201 as Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors Nicolas

Abstract ID: 285

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/600-t05-phase-1-2-open-label-trial-to-assess-the-safety-and-preliminary-efficacy-of-177lu-ops201-as-peptide-receptor-radionuclide-therapy-in-patients-with-somatostatin-receptor-positive-progressive-neuroendocrine-tumors?format=html Nicolas

Abstract ID: 285

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:23:30 -0500 T04 – Multicenter Phase 2 Study of Nintedanib in Patients (pts) with Advanced Progressing Carcinoid Tumors https://nanets.net/abstracts-archive/2017/599-t04-multicenter-phase-2-study-of-nintedanib-in-patients-pts-with-advanced-progressing-carcinoid-tumors?format=html T04 – Multicenter Phase 2 Study of Nintedanib in Patients (pts) with Advanced Progressing Carcinoid Tumors Iyer

Abstract ID: 288

]]> https://nanets.net/abstracts-archive/2017/599-t04-multicenter-phase-2-study-of-nintedanib-in-patients-pts-with-advanced-progressing-carcinoid-tumors?format=html Iyer

Abstract ID: 288

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:23:29 -0500 T02 – A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After At Least One Prior Regimen for Metastatic Disease https://nanets.net/abstracts-archive/2017/597-t02-a-phase-1-study-of-fosbretabulin-in-combination-with-everolimus-in-neuroendocrine-tumors-grades-1-3-that-have-progressed-after-at-least-one-prior-regimen-for-metastatic-disease?format=html T02 – A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After At Least One Prior Regimen for Metastatic Disease Chauhan

Abstract ID: 250

]]> https://nanets.net/abstracts-archive/2017/597-t02-a-phase-1-study-of-fosbretabulin-in-combination-with-everolimus-in-neuroendocrine-tumors-grades-1-3-that-have-progressed-after-at-least-one-prior-regimen-for-metastatic-disease?format=html Chauhan

Abstract ID: 250

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:23:28 -0500 T03 – Pilot Study: Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor https://nanets.net/abstracts-archive/2017/598-t03-pilot-study-yttrium-90-dota-toc-intra-arterial-ia-peptide-receptor-radionuclide-therapy-prrt-for-neuroendocrine-tumor?format=html T03 – Pilot Study: Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor Hope

Abstract ID: 309

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/598-t03-pilot-study-yttrium-90-dota-toc-intra-arterial-ia-peptide-receptor-radionuclide-therapy-prrt-for-neuroendocrine-tumor?format=html Hope

Abstract ID: 309

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:23:28 -0500 T01 – Avelumab in Advanced Neuroendocrine Tumours (NET) of Gastroenteropancreatic or Lung Origin https://nanets.net/abstracts-archive/2017/596-t01-avelumab-in-advanced-neuroendocrine-tumours-net-of-gastroenteropancreatic-or-lung-origin?format=html T01 – Avelumab in Advanced Neuroendocrine Tumours (NET) of Gastroenteropancreatic or Lung Origin Chan

Abstract ID: 295

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/596-t01-avelumab-in-advanced-neuroendocrine-tumours-net-of-gastroenteropancreatic-or-lung-origin?format=html Chan

Abstract ID: 295

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:23:27 -0500 O04 – Pancreatic Neuroendocrine Tumors: CT Enhancement, but not Histologic Grade, Correlates with Tumor Aggression https://nanets.net/abstracts-archive/2017/595-o04-pancreatic-neuroendocrine-tumors-ct-enhancement-but-not-histologic-grade-correlates-with-tumor-aggression?format=html O04 – Pancreatic Neuroendocrine Tumors: CT Enhancement, but not Histologic Grade, Correlates with Tumor Aggression Yano

Abstract ID: 201

]]> https://nanets.net/abstracts-archive/2017/595-o04-pancreatic-neuroendocrine-tumors-ct-enhancement-but-not-histologic-grade-correlates-with-tumor-aggression?format=html Yano

Abstract ID: 201

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:22:25 -0500 O03 – Blood Neuroendocrine Transcript Analysis for the Diagnosis and Clinical Status Assessment of Bronchopulmonary Neuroendocrine Tumors https://nanets.net/abstracts-archive/2017/594-o03-blood-neuroendocrine-transcript-analysis-for-the-diagnosis-and-clinical-status-assessment-of-bronchopulmonary-neuroendocrine-tumors?format=html O03 – Blood Neuroendocrine Transcript Analysis for the Diagnosis and Clinical Status Assessment of Bronchopulmonary Neuroendocrine Tumors Modlin

Abstract ID: 296

]]> https://nanets.net/abstracts-archive/2017/594-o03-blood-neuroendocrine-transcript-analysis-for-the-diagnosis-and-clinical-status-assessment-of-bronchopulmonary-neuroendocrine-tumors?format=html Modlin

Abstract ID: 296

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:22:24 -0500 O02 – The Distal Predilection of Small Bowel Neuroendocrine Tumors https://nanets.net/abstracts-archive/2017/593-o02-the-distal-predilection-of-small-bowel-neuroendocrine-tumors?format=html O02 – The Distal Predilection of Small Bowel Neuroendocrine Tumors Keck

Abstract ID: 211

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/593-o02-the-distal-predilection-of-small-bowel-neuroendocrine-tumors?format=html Keck

Abstract ID: 211

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:22:23 -0500 O01 – Integrating Patient Reported Outcomes (PROs) in Neuroendocrine Tumors (NETs) Care: An Assessment of Neuropsychological and Quality of Life Screening Tools https://nanets.net/abstracts-archive/2017/592-o01-integrating-patient-reported-outcomes-pros-in-neuroendocrine-tumors-nets-care-an-assessment-of-neuropsychological-and-quality-of-life-screening-tools?format=html O01 – Integrating Patient Reported Outcomes (PROs) in Neuroendocrine Tumors (NETs) Care: An Assessment of Neuropsychological and Quality of Life Screening Tools Hallet

Abstract ID: 230

]]> https://nanets.net/abstracts-archive/2017/592-o01-integrating-patient-reported-outcomes-pros-in-neuroendocrine-tumors-nets-care-an-assessment-of-neuropsychological-and-quality-of-life-screening-tools?format=html Hallet

Abstract ID: 230

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:22:22 -0500 P12 – Ovarian Metastasis from Midgut Neuroendocrine Tumors: Incidence, Clinical Implications, and Management Options—An Update https://nanets.net/abstracts-archive/2017/591-p12-ovarian-metastasis-from-midgut-neuroendocrine-tumors-incidence-clinical-implications-and-management-options-an-update?format=html P12 – Ovarian Metastasis from Midgut Neuroendocrine Tumors: Incidence, Clinical Implications, and Management Options—An Update Wang

Abstract ID: 258

]]> https://nanets.net/abstracts-archive/2017/591-p12-ovarian-metastasis-from-midgut-neuroendocrine-tumors-incidence-clinical-implications-and-management-options-an-update?format=html Wang

Abstract ID: 258

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:36 -0500 P10 – Somatostatin Analog Usage in Neuroendocrine Tumors: A Retrospective Database Analysis https://nanets.net/abstracts-archive/2017/589-p10-somatostatin-analog-usage-in-neuroendocrine-tumors-a-retrospective-database-analysis?format=html P10 – Somatostatin Analog Usage in Neuroendocrine Tumors: A Retrospective Database Analysis Klink

Abstract ID: 234

]]> https://nanets.net/abstracts-archive/2017/589-p10-somatostatin-analog-usage-in-neuroendocrine-tumors-a-retrospective-database-analysis?format=html Klink

Abstract ID: 234

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:35 -0500 P11 – Evaluation of the Impact of the Burden of Carcinoid Syndrome Symptoms on Quality of Life Among Treated Patients with Carcinoid Syndrome in the U.S. Based on the PROMIS–29 Instrument https://nanets.net/abstracts-archive/2017/590-p11-evaluation-of-the-impact-of-the-burden-of-carcinoid-syndrome-symptoms-on-quality-of-life-among-treated-patients-with-carcinoid-syndrome-in-the-u-s-based-on-the-promis-29-instrument?format=html P11 – Evaluation of the Impact of the Burden of Carcinoid Syndrome Symptoms on Quality of Life Among Treated Patients with Carcinoid Syndrome in the U.S. Based on the PROMIS–29 Instrument Neary

Abstract ID: 244

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/590-p11-evaluation-of-the-impact-of-the-burden-of-carcinoid-syndrome-symptoms-on-quality-of-life-among-treated-patients-with-carcinoid-syndrome-in-the-u-s-based-on-the-promis-29-instrument?format=html Neary

Abstract ID: 244

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:35 -0500 P09 – International Patient Survey of Physical, Emotional, and Informational Challenges when Living with Neuroendocrine Tumors: Understanding the Unmet Needs https://nanets.net/abstracts-archive/2017/588-p09-international-patient-survey-of-physical-emotional-and-informational-challenges-when-living-with-neuroendocrine-tumors-understanding-the-unmet-needs?format=html P09 – International Patient Survey of Physical, Emotional, and Informational Challenges when Living with Neuroendocrine Tumors: Understanding the Unmet Needs Khan

Abstract ID: 266

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/588-p09-international-patient-survey-of-physical-emotional-and-informational-challenges-when-living-with-neuroendocrine-tumors-understanding-the-unmet-needs?format=html Khan

Abstract ID: 266

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:34 -0500 P08 – Assessment of the Association Between the Burden of Carcinoid Syndrome Symptoms and the Quality of Life Among Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument https://nanets.net/abstracts-archive/2017/587-p08-assessment-of-the-association-between-the-burden-of-carcinoid-syndrome-symptoms-and-the-quality-of-life-among-patients-with-carcinoid-syndrome-in-the-united-states-based-on-the-fact-g-instrument?format=html P08 – Assessment of the Association Between the Burden of Carcinoid Syndrome Symptoms and the Quality of Life Among Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument Huynh

Abstract ID: 245

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/587-p08-assessment-of-the-association-between-the-burden-of-carcinoid-syndrome-symptoms-and-the-quality-of-life-among-patients-with-carcinoid-syndrome-in-the-united-states-based-on-the-fact-g-instrument?format=html Huynh

Abstract ID: 245

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:33 -0500 P07 – Association Between Duration of Somatostatin Analogs (SSAs) Use and Quality of Life in Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument https://nanets.net/abstracts-archive/2017/586-p07-association-between-duration-of-somatostatin-analogs-ssas-use-and-quality-of-life-in-patients-with-carcinoid-syndrome-in-the-united-states-based-on-the-fact-g-instrument?format=html P07 – Association Between Duration of Somatostatin Analogs (SSAs) Use and Quality of Life in Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument Halperin

Abstract ID: 243

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/586-p07-association-between-duration-of-somatostatin-analogs-ssas-use-and-quality-of-life-in-patients-with-carcinoid-syndrome-in-the-united-states-based-on-the-fact-g-instrument?format=html Halperin

Abstract ID: 243

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:32 -0500 P06 – Carcinoid Tumors of the Ovary: An Observational Cohort Study of 67 Primary and Metastatic Cases https://nanets.net/abstracts-archive/2017/585-p06-carcinoid-tumors-of-the-ovary-an-observational-cohort-study-of-67-primary-and-metastatic-cases?format=html P06 – Carcinoid Tumors of the Ovary: An Observational Cohort Study of 67 Primary and Metastatic Cases Feingold

Abstract ID: 280

 Download Poster

]]> https://nanets.net/abstracts-archive/2017/585-p06-carcinoid-tumors-of-the-ovary-an-observational-cohort-study-of-67-primary-and-metastatic-cases?format=html Feingold

Abstract ID: 280

 Download Poster

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:31 -0500 P04 – Treatment Response and Clinical Outcomes of Poorly Differentiated (PD) Grade 3 (G3) Gallbladder Neuroendocrine Carcinomas (NEC): A Single Institution Experience https://nanets.net/abstracts-archive/2017/583-p04-treatment-response-and-clinical-outcomes-of-poorly-differentiated-pd-grade-3-g3-gallbladder-neuroendocrine-carcinomas-nec-a-single-institution-experience?format=html P04 – Treatment Response and Clinical Outcomes of Poorly Differentiated (PD) Grade 3 (G3) Gallbladder Neuroendocrine Carcinomas (NEC): A Single Institution Experience Corbett

Abstract ID: 283

]]> https://nanets.net/abstracts-archive/2017/583-p04-treatment-response-and-clinical-outcomes-of-poorly-differentiated-pd-grade-3-g3-gallbladder-neuroendocrine-carcinomas-nec-a-single-institution-experience?format=html Corbett

Abstract ID: 283

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:30 -0500 P05 – Carcinoid Heart Disease in Patients with Bronchopulmonary Carcinoid https://nanets.net/abstracts-archive/2017/584-p05-carcinoid-heart-disease-in-patients-with-bronchopulmonary-carcinoid?format=html P05 – Carcinoid Heart Disease in Patients with Bronchopulmonary Carcinoid De Jesus

Abstract ID: 275

]]> https://nanets.net/abstracts-archive/2017/584-p05-carcinoid-heart-disease-in-patients-with-bronchopulmonary-carcinoid?format=html De Jesus

Abstract ID: 275

]]> support@adgcommunications.com (Super User) 2017 Thu, 15 Feb 2018 14:21:30 -0500